Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+T cells to proliferate and secrete interferon-γ

被引:64
作者
Dotan, Iris [1 ]
Allez, Matthieu [1 ]
Nakazawa, Atsushi [1 ]
Brimnes, Jens [1 ]
Schulder-Katz, Micoll [1 ]
Mayer, Lloyd [1 ]
机构
[1] Mt Sinai Sch Med, Immunobiol Ctr, New York, NY USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2007年 / 292卷 / 06期
关键词
mucosal inflammation; Crohn's disease; ulcerative colitis; interferon-gamma; cytokines;
D O I
10.1152/ajpgi.00294.2006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Previous studies have suggested that intestinal epithelial cells ( IECs) have the capacity to function as nonprofessional antigen presenting cells that in the normal state preferentially activate CD8+ T cells. However, under pathological conditions, such as those found in inflammatory bowel disease (IBD), persistent activation of CD4+ T cells is seen. The aim of this study was to determine whether the IBD IECs contribute to CD4+ T cell activation. Freshly isolated human IECs were obtained from surgical specimens of patients with or without IBD and cocultured with autologous or allogeneic peripheral blood T lymphocytes. Cocultures of normal T cells and IECs derived from IBD patients resulted in the preferential activation of CD4+ T cell proliferation that was associated with significant IFN-gamma, but not IL-2, secretion. Cytokine secretion and CD4+ T cell proliferation was inhibited by pretreatment of the IBD IECs with the anti- DR MAb L243. In contrast, normal IECs stimulated the proliferation and cytokine secretion by CD4+ T cells to a significantly lesser degree than IBD IECs. Furthermore, blockade of human leukocyte antigen- DR had a lesser effect in the normal IEC- CD4+ T cell cocultures. We conclude that IECs can contribute to the ongoing CD4+ T cell activation seen in IBD. We suggest that the apparent differences between the secreted levels of IFN-gamma indicate that it may play a dual role in intestinal homeostasis, in which low levels contribute to physiological inflammation whereas higher levels are associated with an uncontrolled inflammatory state.
引用
收藏
页码:G1630 / G1640
页数:11
相关论文
共 66 条
[1]  
Akagi S, 2000, INT J MOL MED, V5, P389
[2]   Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells [J].
Allez, M ;
Brimnes, J ;
Dotan, I ;
Mayer, L .
GASTROENTEROLOGY, 2002, 123 (05) :1516-1526
[3]   Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice:: Control by CD4+ regulatory T cells and IL-10 [J].
Asseman, C ;
Read, S ;
Powrie, F .
JOURNAL OF IMMUNOLOGY, 2003, 171 (02) :971-978
[4]  
BREESE E, 1993, IMMUNOLOGY, V78, P127
[5]   Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease [J].
Brimnes, J ;
Allez, M ;
Dotan, I ;
Shao, L ;
Nakazawa, A ;
Mayer, L .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5814-5822
[6]   Altered expression of inteferon-γ and interleukin-4 in inflammatory bowel disease [J].
Camoglio, L ;
Velde, AAT ;
Tigges, TJ ;
Das, PK ;
Van Deventer, SJH .
INFLAMMATORY BOWEL DISEASES, 1998, 4 (04) :285-290
[7]   The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells [J].
Campbell, NA ;
Kim, HS ;
Blumberg, RS ;
Mayer, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26259-26265
[8]   REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CHEN, YH ;
KUCHROO, VK ;
INOBE, J ;
HAFLER, DA ;
WEINER, HL .
SCIENCE, 1994, 265 (5176) :1237-1240
[9]   Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6112-6119
[10]   CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864